首页> 外文期刊>Genewatch : >AMP v. Myriad: Preliminary Reflections The story behind the groundbreaking Supreme Court decision.
【24h】

AMP v. Myriad: Preliminary Reflections The story behind the groundbreaking Supreme Court decision.

机译:AMP诉Myriad:初步思考最高法院一项具有开创性的裁决背后的故事。

获取原文
获取原文并翻译 | 示例
       

摘要

On June 13th, the Supreme Court issued a unanimous decision in Association for Molecular Pathology v. Myriad Genetics that held that genomic DNA cannot be patented. Specifically, the opinion, written by Justice Thomas, found that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated."
机译:6月13日,最高法院在“分子病理学协会诉无数遗传学”一案中作出一致裁定,裁定不能对基因组DNA申请专利。具体来说,由托马斯大法官(Thomas Thomas)撰写的意见发现,“天然存在的DNA片段是自然产物,而不是仅仅因为其被分离而没有专利资格”。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号